Public Health
Volume 121, Issue 6 , Pages 462-468 , June 2007

Rubella seroprevalence in an unvaccinated pregnant population in Malatya, Turkey

  • E. Pehlivan

      Affiliations

    • Faculty of Medicine, Department of Public Health, Inonu University, Malatya, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +9004223410660.
    • ,
  • L. Karaoglu

      Affiliations

    • Faculty of Medicine, Department of Public Health, Inonu University, Malatya, Turkey
    • ,
  • M. Ozen

      Affiliations

    • Faculty of Medicine, Department of Paediatrics, Inonu University, Malatya, Turkey
    • ,
  • G. Gunes

      Affiliations

    • Faculty of Medicine, Department of Paediatrics, Inonu University, Malatya, Turkey
    • ,
  • M.S. Tekerekoglu

      Affiliations

    • Faculty of Medicine, Department of Microbiology, Inonu University, Malatya, Turkey
    • ,
  • M.F. Genc

      Affiliations

    • Faculty of Medicine, Department of Public Health, Inonu University, Malatya, Turkey
    • ,
  • M. Egri

      Affiliations

    • Faculty of Medicine, Department of Public Health, Inonu University, Malatya, Turkey
    • ,
  • C. Ercan

      Affiliations

    • Faculty of Medicine, Department of Public Health, Inonu University, Malatya, Turkey

Received 11 January 2006 ,Revised 18 August 2006 ,Accepted 30 September 2006.

References 

  1. Chin J, Ascher MS, editors. Control of communicable diseases manuel, 17th ed. Washington, DC: American Public Health Association; 2000. p. 435–40.
  2. World Health Organization. Report of a meeting on preventing congenital rubella syndrome: immunization strategies, surveillance needs. Experiences with congenital rubella syndrome prevention and rubella control in the Americas (WHO/V&B/00.10:20). Geneva: The World Health Organization; 2000.
  3. Stanley FJ, Sim M, Wilson G, Worthington S. The decline in congenital rubella syndrome in Western Australia: an impact of the school girl vaccination program. Am J Public Health. 1986;76:35–37
  4. Condon RJ, Bower C. Rubella vaccination and congenital rubella syndrome in Western Australia. Med J Aust. 1993;158:379–382
  5. Jamrozik K, Hobbs M. Medical care and public health. In:  Detels R,  McEwen J,  Beaglehole R,  Tanaka H editor. Oxford textbook of public health. 4th ed. New York: Oxford University Press; 2002;p. 215–242
  6. Anderson R, Nokes DJ. Mathematical models of transmission and control. In:  Detels R,  McEwen J,  Beaglehole R,  Tanaka H editor. Oxford textbook of public health. New York: Oxford University Press; 2002;p. 715–744
  7. World Health Organization Europe. Strategic plan for measles and congenital rubella infection in the European Region of WHO. World Health Organization Europe, 2003. Available from: 〈http://www.euro.who.int/document/e81567.pdf〉 (accessed 26 October 2005).
  8. TC Saglik Bakanligi (Turkish Republic Ministry of Health). Bulaşıcı hastalıkların ihbarı ve bildirim sistemi, standart tanı, sürveyans ve laboratuar rehberi—2004 (A guideline for laboratory surveillance, standard diagnosis, denunciation and announcement system for infectious diseases—2004). Ankara: TC Sağlık Bakanlığı (TR Ministry of Health); 2004.
  9. Aksakal NF, Maral I. Rubella vaccine. Türkiye Klinikleri J Ped. 2004;2:997–1002
  10. Aksit S, Egemen A, Ozacar T, Kurugol Z, Keskinoglu P, Tasbakan M, et al. Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey. Pediatr Infect Dis J. 1999;18:577–580
  11. Research methods for developing countries. (HSERV/EPI 539). From Winter Quarter 2005 Online lecture notes. Available from 〈http://courses.washington.edu/hserv539/docs/SamplingIandII.doc〉 (last accessed 30 September 2006).
  12. World Health Organization. Facilitator guide for the EPI coverage survey. Available from: 〈http://www.who.int/immunization_monitoring/routine/Facilitator_guide_EPI_coverage_survey.pdf〉 (last accessed 30 September 2006).
  13. Aksit S, Timocin A, Turpculu A. Rubella immunity in pregnant Turkish women. Int J Gynaecol Obstet. 1999;66:33–34
  14. Dilmen U, Kaya S, Ciftci U, Göksin E. Rubella and toxoplasmosis in gestation, stillborn babies and in aborts. Doga Tr Med Sci. 1990;14:294–300
  15. Guner H, Gunay A, Rota S. Seroprevalence of rubella virus in Turkish pregnant women. Int J Gynecol Obstet. 1994;44:139–141
  16. Karakoc GB, Altintas DU, Kilinc B, Karabay A, Mungan NO, Yilmaz M, et al. Seroprevalence of rubella in school girls and pregnant women. Eur J Epidemiol. 2003;18:81–84
  17. Castillo-Solorzano C, Andrus JK. Rubella elimination and improving health care for women. Emerg Infect Dis. 2004;10:2017–2021
  18. Ulusal Aşı Sempozyumu (First national vaccine symposium). Available from: 〈http://www.valortr.com/asi2005/#〉 (slides available) (last accessed 30 September 2006).
  19. Measles and congenital rubella infection. Copenhagen: WHO Regional Office for Europe; 2005. Available from:〈http://www.euro.who.int/vaccine/20030808_4〉 (last accessed 30 September 2006).
  20. T.C. Saglik Bakanligi (T.R. Ministry of Health). Temel Sağlık Hizmetleri Genel Müdürlüğü 2004 Çalışma Yıllığı (Basic Health Service General Directorate 2004 Work Report). Ankara: Temel Sağlık Hizmetleri Yayınları (Basic Health Service Publication); Ekim 2005 (October 2005). p. 66–79.
  21. Ay P, Topuzoglu A, Korukluoglu G, Cali S. Rubella seroprevalence among first-grade primary school students in a district in İstanbul, Turkey. Public Health. 2006;120:267–273
  22. Hinman AR, Irons B, Lewis M, Kandola K. Economic analyses of rubella and rubella vaccines: a global review. Bull World Health Organ. 2002;80:264–270
  23. Stray-Pedersen B. Economic evaluation of different vaccination programmes to prevent congenital rubella. NIPH Ann (Norway). 1982;5:69–81

PII: S0033-3506(06)00327-1

doi: 10.1016/j.puhe.2006.09.021

Public Health
Volume 121, Issue 6 , Pages 462-468 , June 2007

Article Tools